PEOPLE - Chiron Vision Europe announces appointments:
This article was originally published in Clinica
Chiron Vision Europe has announced two key appointments to its European management board. Michael O'Rourke is appointed European marketing director. He has spent 14 years in the pharmaceutical, dental and orthopaedic industry. Ian Davies has joined from Telectronics. He will establish a centralised customer service function base in Lyons, France.
You may also be interested in...
UK start up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country.
As Bharat Biotech prepares its COVID-19 vaccine for a launch in the quarter ending next 30 September and claims at least 60% efficacy, questions arise over why trials were not temporarily halted following a serious adverse event during Phase I and why this wasn’t disclosed to participants in subsequent studies.
Highlighting progress it has made over the past few years, Japan’s regulatory agency says it wants to raise even further the number of “Japan-first” approvals, as part of its stated mission to get safe and effective new drugs to patients more quickly.